Similar articles for PMID: 32639938

Year	Number of Results
1950	1
2005	1
2009	1
2010	1
2011	1
2012	2
2013	9
2014	14
2015	13
2016	15
2017	12
2018	4
2019	5
2020	1
2021	1
2022	0

1

Device-based therapies for resistant hypertension in chronic kidney disease: The continuing quest for a cure.

Thomas G. Thomas G. Cleve Clin J Med. 2020 Jun 30;87(7):444-447. doi: 10.3949/ccjm.87a.20092. Cleve Clin J Med. 2020. PMID: 32639938 Free article. No abstract available.

2

Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.

de Beus E, Bots ML, van Zuilen AD, Wetzels JF, Blankestijn PJ; MASTERPLAN Study Group. de Beus E, et al. Hypertension. 2015 Nov;66(5):998-1005. doi: 10.1161/HYPERTENSIONAHA.115.05694. Epub 2015 Sep 8. Hypertension. 2015. PMID: 26351024

3

Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.

Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER 3rd, Steigerwalt SP, Townsend RR, Weir MR, Wright JT Jr, Rahman M; CRIC Study Investigators. Thomas G, et al. Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28. Hypertension. 2016. PMID: 26711738 Free PMC article.

4

The double challenge of resistant hypertension and chronic kidney disease.

Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D; ERA-EDTA EURECA-m working group; Red de Investigación Renal (REDINREN) network; Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network. Rossignol P, et al. Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3. Lancet. 2015. PMID: 26530623 Review.

5

Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.

Sinnakirouchenan R, Kotchen TA. Sinnakirouchenan R, et al. Semin Nephrol. 2014;34(5):514-9. doi: 10.1016/j.semnephrol.2014.08.005. Semin Nephrol. 2014. PMID: 25416660 Review.

6

Pathophysiology of resistant hypertension in chronic kidney disease.

Campese VM. Campese VM. Semin Nephrol. 2014;34(5):571-6. doi: 10.1016/j.semnephrol.2014.08.011. Semin Nephrol. 2014. PMID: 25416666 Review.

7

Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.

Wolley MJ, Stowasser M. Wolley MJ, et al. Curr Hypertens Rep. 2016 Apr;18(5):36. doi: 10.1007/s11906-016-0641-x. Curr Hypertens Rep. 2016. PMID: 27072829 Review.

8

Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.

Sarafidis PA, Georgianos PI, Zebekakis PE. Sarafidis PA, et al. Semin Nephrol. 2014;34(5):483-91. doi: 10.1016/j.semnephrol.2014.08.001. Semin Nephrol. 2014. PMID: 25416656 Review.

9

[Resistant hypertension and chronic kidney disease: epidemiology and prognosis].

Seidowsky A, Massy ZA, Metzger M, Stengel B. Seidowsky A, et al. Nephrol Ther. 2014 Jun;10(3):137-44. doi: 10.1016/j.nephro.2013.12.006. Epub 2014 Apr 13. Nephrol Ther. 2014. PMID: 24726612 Review. French.

10

Renal artery stenting of chronic kidney disease patient with resistant hypertension.

Çoner A, Çiçek D, Akıncı S, Müderrisoğlu H. Çoner A, et al. Anatol J Cardiol. 2016 Nov;16(11):894-895. doi: 10.14744/AnatolJCardiol.2016.7365. Anatol J Cardiol. 2016. PMID: 27872437 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed